THE SHIELD IS CRACKING
How the 2018 Farm Bill buried the Federal Analogue Act — and how P.L. 119-37 is quietly digging it back up
By Jay Maguire, Political Editor | Texas Hemp Reporter / Blazed News | March 31, 2026
There is a law most hemp retailers have never heard of that has always had their name on it. The Federal Analogue Act of 1986 was designed to be the DEA’s Swiss Army knife against designer drugs — a statute authorizing the government to treat any chemical “substantially similar” to a Schedule I substance as if Congress had already scheduled it, provided the substance was intended for human consumption. Delta-8 THC, an isomer sharing nearly identical molecular architecture with delta-9 and producing similar intoxicating effects, was a textbook candidate for analogue prosecution before 2018. So was THCA, as a direct precursor. For roughly three decades, the FAA was the silent sword hanging over the market — not because prosecution was certain, but because it was always possible.
Then the 2018 Farm Bill built a shield. Section 781 of P.L. 119-37 is quietly dismantling it.
ACT ONE: HOW THE FARM BILL KILLED THE ANALOGUE THEORY
The Agriculture Improvement Act of 2018 did something legally elegant and historically consequential: it defined hemp as Cannabis sativa L. and any part of that plant, including “all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers,” and simultaneously amended the CSA to exclude hemp from the definition of marijuana. It also carved out “THC in hemp” from federal scheduling of tetrahydrocannabinols. With one piece of agricultural legislation, Congress essentially told the DEA: if it comes from this plant and stays under 0.3% delta-9 THC, you have no case.
The DEA’s instinct was predictably resistant. A series of opinion letters argued that “synthetically derived” THC — meaning, essentially, delta-8 produced by isomerizing CBD — remained Schedule I regardless of the Farm Bill. But those letters were advisory, non-binding, and ultimately pre-empted by what Congress had written. The question of whether the Farm Bill’s carve-out actually reached cannabinoids like delta-8 waited for a court to settle it. The answer arrived, with considerable irony, through a counterfeiting dispute over knockoff vape cartridges.
In May 2022, the U.S. Court of Appeals for the Ninth Circuit handed down AK Futures LLC v. Boyd Street Distro, LLC. The plaintiff, AK Futures, manufactured Cake-branded delta-8 vape products; the defendant was selling counterfeits. Boyd Street’s defense was that AK Futures couldn’t hold a valid trademark because its products were federally illegal. The Ninth Circuit was not persuaded. The Farm Bill’s plain and unambiguous text, the court held, compelled the conclusion that delta-8 THC products derived from compliant hemp are lawful. The source of the product — cannabis — controlled the legal analysis, not the manufacturing method. The DEA’s “synthetic” argument was dispatched with the observation that nothing in the Farm Bill defined hemp’s derivatives by how they were produced. And on congressional intent, the court offered what has since become something of an industry scripture: “If Congress inadvertently created a loophole legalizing vaping products containing delta-8 THC, then it is for Congress to fix its mistake.”
The FAA implications were direct and structural. Once the Ninth Circuit established that hemp-derived delta-8 was expressly covered by a statutory exemption, the analogue classification couldn’t stick. You cannot be an illegal analogue of a substance if you are already expressly carved out by statute. The shield was complete. The Fourth Circuit later aligned with the Ninth, confirming the analysis while separately upholding states’ authority to regulate more strictly — relevant to Texas, but untouching the core federal preemption logic as to the FAA.
A NOTE ON THE FAA’S TWO-PART TEST
To prosecute a substance under the Federal Analogue Act, the government must prove: first, that the substance has a substantially similar chemical structure to a Schedule I or II controlled substance; and second, that it produces a substantially similar stimulant, depressant, or hallucinogenic effect on the central nervous system. Delta-8 THC and THCA satisfy both prongs with minimal analytical effort. Before AK Futures, the only barrier to analogue prosecution was prosecutorial discretion. After AK Futures, the Farm Bill’s statutory carve-out provided a genuine legal defense. After November 12, 2026, for a significant category of products, that defense begins to erode.
ACT TWO: CONGRESS TAKES THE COURT’S ADVICE
President Trump signed P.L. 119-37 — a government funding bill formally titled the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 — on November 12, 2025. Section 781 of Division B rewrites the federal definition of hemp. The provision doesn’t take effect immediately; it becomes operative exactly 365 days after enactment, on November 12, 2026. That one-year runway has lulled many operators into treating the deadline as distant and abstract. It is neither.
Section 781 effectuates three principal changes. First, it replaces the delta-9-only threshold with a total THC standard, inclusive of THCA and delta-8, still at or below 0.3% on a dry-weight basis. Second, products containing cannabinoids synthesized or manufactured outside the cannabis plant are no longer hemp — which directly targets the CBD-to-delta-8 isomerization chemistry that the Ninth Circuit had blessed in AK Futures. Third, finished hemp-derived cannabinoid products may contain no more than 0.4 milligrams of total THC per container. Current market products typically contain between 2.5 and 10 milligrams per unit, meaning they exceed this threshold by a factor of six to twenty-five.
The mechanism by which this re-criminalizes the market is indirect but lethal. Because the CSA excludes “hemp” by cross-reference to the Agricultural Marketing Act, narrowing the hemp definition pushes many currently marketed products back into Schedule I status. The Congressional Research Service’s own analysis describes the amendment as operating as “an exception to the exceptions” — meaning covered hemp-derived cannabinoid products will be subject to CSA regulation as marijuana or THC. The Farm Bill shield was built on the Farm Bill’s hemp definition. Narrow the definition, and the shield shrinks with it. The FAA, while not the primary enforcement vehicle, becomes relevant again for products that fall into the gap: substances with the molecular profile of a scheduled drug and no longer any statutory defense to analogue prosecution.
The practical scope is staggering. The U.S. Hemp Roundtable estimates the amended definition would eliminate approximately 95% of existing hemp-derived cannabinoid products, with losses of over 300,000 jobs and $1.5 billion in aggregate state tax revenue. The damage is not confined to intoxicating products: the 0.4-milligram container threshold sweeps up a broad range of non-intoxicating CBD wellness products marketed for sleep, anxiety, and pain management that had nothing to do with the public-safety concerns that animated the legislation.
THE ENFORCEMENT QUESTION NO ONE WILL ANSWER HONESTLY
The Congressional Research Service has acknowledged what no one in the executive branch will say plainly: it is “unclear” how federal law enforcement will enforce the new prohibitions. Both FDA and DEA may lack the resources to broadly pursue intoxicating hemp products that persist on the market after November 2026. The federal government’s long-standing posture toward state-legal cannabis — nominal illegality, practical tolerance — may extend here as well.
But “unclear enforcement” is cold comfort for a retailer or distributor who finds themselves federally indicted on the basis that their product is no longer hemp and therefore constitutes either marijuana or a scheduled THC compound. The Federal Analogue Act may be dormant, but it never died. After November 12, 2026, for products falling outside the new hemp definition, the FAA’s two-part test — similar structure, similar effect — once again describes the product without a statutory defense to meet it. The question is who pulls the trigger and on whom. History suggests the answer is: on whoever is most visible, most politically inconvenient, or most geographically unlucky.
Texas operators who have survived a year of Dan Patrick’s moral panic, watched DSHS rewrite the rulebook by executive fiat, and are now absorbing the costs of smokeable hemp removal from their shelves should understand that the federal deadline is not Dan Patrick’s problem to create. It was created by Congress, it was signed by the President, and it arrives in November regardless of what happens in Travis County.
WHAT CONGRESS IS TRYING TO DO ABOUT IT
The industry has not been passive. Representative Nancy Mace introduced the American Hemp Protection Act of 2025 to strike Section 781 in its entirety and restore the 2018 Farm Bill definition. The Hemp Planting Predictability Act seeks simply to extend the implementation deadline, buying time without relitigating the underlying policy. The most substantive alternative is the Cannabinoid Safety and Regulation Act introduced by Senators Wyden and Merkley — an 84-page framework that would replace the prohibition with a regulated market: 5 milligrams per serving and 50 milligrams per container for edibles, a federal minimum age of 21, mandatory third-party testing, and standardized labeling. An explicit savings clause preserves states’ authority to be stricter still. House Agriculture Committee Chairman Glenn Thompson has separately filed a 2026 Farm Bill draft that touches these same questions.
None of these measures has passed. None is currently guaranteed to pass. The window is November 12, 2026. That is less than eight months from today.
WHAT TEXAS OPERATORS NEED TO UNDERSTAND RIGHT NOW
The DSHS fight — the administrative overreach challenge, the Sky Marketing injunction, the APA and ultra vires arguments moving through Travis County — is a real fight that matters. A successful injunction restoring the pre-March 31 regulatory framework is worth winning, both for the operators it protects and for the precedent it sets about the limits of executive agency rulemaking. Win it.
But winning it does not solve November 2026. Even if every pending legal challenge succeeds, even if the DSHS rules are enjoined, vacated, and set on fire, the federal clock keeps running. A DSHS rollback buys time in a state fight while a larger federal cliff approaches in seven and a half months. The products Texas retailers are fighting to keep on shelves today face a second, federally-imposed reckoning that has nothing to do with Greg Abbott or Dan Patrick.
The strategic implication is that the Texas fight and the federal fight are not sequential — they are simultaneous, and they require the same underlying argument. The case for a federal regulatory framework rather than a federal prohibition rests on one claim: that responsible industry actors have been self-regulating in the absence of coherent statutory guidance. That means COA compliance. That means CRAFT certification. That means documented SOPs, age verification, child-resistant packaging, and the full architecture of an industry that behaves as though it expects to be taken seriously. Those are not merely compliance burdens. They are the evidentiary record that separates the operators who deserve a regulatory pathway from the ones who validated every concern that produced Section 781 in the first place. Texas operators who can point to that record are the face that federal legislators need when they argue that regulation is preferable to prohibition — and that prohibition, when it arrives without a regulated alternative, hands the market to precisely the people it was designed to keep out.
The Federal Analogue Act did not disappear in 2018. It was preempted by statute — a statute whose definition is now being rewritten. The window between now and November 12, 2026 is not a grace period.
It is a lobbying deadline. And the clock that the Ninth Circuit handed to Congress in 2022 is almost out of time.
Jay Maguire is Political Editor of the Texas Hemp Reporter and Blazed News, Executive Director of the Texas Hemp Federation, and co-founder of CRAFT (Cannabis Retail Alliance For Texas). He is a political strategist and public affairs consultant operating through Maguire Strategies.